HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,219,975 | -41.1% | 19,189 | -47.7% | 0.00% | -42.9% |
Q2 2023 | $3,770,481 | -2.4% | 36,660 | +3.6% | 0.01% | 0.0% |
Q1 2023 | $3,862,137 | -84.3% | 35,387 | -83.7% | 0.01% | -85.4% |
Q4 2022 | $24,664,329 | +50.4% | 216,734 | -18.2% | 0.05% | +45.5% |
Q3 2022 | $16,396,000 | -90.9% | 264,922 | -88.3% | 0.03% | -80.8% |
Q2 2022 | $180,983,000 | -37.2% | 2,269,095 | -17.2% | 0.17% | -20.0% |
Q1 2022 | $288,209,000 | -5.4% | 2,739,365 | -3.1% | 0.22% | +1.4% |
Q4 2021 | $304,736,000 | -7.5% | 2,827,720 | -5.9% | 0.21% | -17.2% |
Q3 2021 | $329,327,000 | +19.8% | 3,006,452 | +2.4% | 0.26% | +9.4% |
Q2 2021 | $274,918,000 | +3.1% | 2,935,892 | +1.3% | 0.23% | -9.7% |
Q1 2021 | $266,689,000 | +13.8% | 2,897,538 | -9.6% | 0.26% | +12.1% |
Q4 2020 | $234,366,000 | -17.9% | 3,203,916 | -12.9% | 0.23% | -30.4% |
Q3 2020 | $285,614,000 | +111.8% | 3,676,798 | +51.5% | 0.33% | +112.8% |
Q2 2020 | $134,881,000 | +120.7% | 2,426,809 | +17.6% | 0.16% | +90.2% |
Q1 2020 | $61,122,000 | +46.1% | 2,063,543 | +78.6% | 0.08% | +115.8% |
Q4 2019 | $41,831,000 | +20.3% | 1,155,541 | -9.4% | 0.04% | +11.8% |
Q3 2019 | $34,779,000 | +33.5% | 1,275,614 | +17.8% | 0.03% | +41.7% |
Q2 2019 | $26,055,000 | – | 1,082,865 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |